Loading...
Docoh

Krystal Biotech (KRYS)

Employees
Data from SEC filings
Employee count
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


On May 20, 2022, Krystal Biotech, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders (the “Annual Meeting”). Set forth below are the matters acted upon at the Annual Meeting and the final voting results on each matter.


Proposal One: Election of Class II Directors


The Company’s stockholders elected Daniel S. Janney, Dino A. Rossi, and E. Rand Sutherland as members of the Company’s Board of Directors as Class II directors for a three-year term. The results of the vote were as follows:
NomineeVotes ForVotes WithheldBroker Non-Votes
Daniel S. Janney16,477,0533,359,6412,292,505
Dino A. Rossi16,642,7373,193,9572,292,505
E. Rand Sutherland19,828,3608,3342,292,505



Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm


The Company’s stockholders ratified the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. The results of the vote were as follows:
Votes ForVotes AgainstAbstentions
21,966,7533,157159,289



Proposal Three: Non-Binding, Advisory Vote On Named Executive Officer Compensation


The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers for the fiscal year ended December 31, 2021, as disclosed in the Company’s proxy statement for the Annual Meeting pursuant to the compensation disclosure rules of the Securities and Exchange Commission. The results of the vote were as follows:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
16,441,3503,335,42459,9202,292,505





Proposal Four: Non-Binding, Advisory Vote on the Frequency of Advisory Votes on Named Executive Officer Compensation


The Company’s stockholders recommended, on an advisory (non-binding) basis, every year as the frequency of future advisory votes on the compensation of the Company’s named executive officers. The results of the vote were as follows:
Every YearTwo YearsThree YearsAbstentions
19,579,3831,326196,68959,296



Based on these voting results, and the recommendation of the Company’s Board of Directors that was included in the proxy statement for the Annual Meeting, the Company has determined that it will hold future advisory votes on the compensation of the Company’s named executive officers on an annual basis until the next stockholder advisory vote on the frequency of future advisory votes on the compensation of the Company’s named executive officers.